Phosphorylase inhibitors
Phosphorylase inhibitors are compounds that interfere with the activity of phosphorylases, enzymes crucial for the metabolism of glycogen. These inhibitors act by binding to phosphorylase enzymes, thereby preventing their normal function of catalyzing the breakdown of glycogen into glucose-1-phosphate. By inhibiting phosphorylase activity, these compounds can regulate glycogenolysis, the process by which glycogen stores are mobilized to release glucose into the bloodstream. This regulation is important in maintaining blood glucose levels during periods of fasting or increased energy demand. Pharmacologically, phosphorylase inhibitors are studied for their potential therapeutic applications in metabolic disorders such as glycogen storage diseases, where abnormal glycogen metabolism leads to pathological conditions.
- Structure
- Product name
- CAS No.
- Molecular formula
- Inquiry
Total:1 Page 1 of 1 1
